Amdocs (DOX) Gains from Sales and Divestitures (2016 - 2025)
Amdocs (DOX) has disclosed Gains from Sales and Divestitures for 9 consecutive years, with $932000.0 as the latest value for Q3 2025.
- On a quarterly basis, Gains from Sales and Divestitures rose 370.71% to $932000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $932000.0, a 370.71% increase, with the full-year FY2025 number at $932000.0, up 370.71% from a year prior.
- Gains from Sales and Divestitures was $932000.0 for Q3 2025 at Amdocs, up from $198000.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $932000.0 in Q3 2025 to a low of $198000.0 in Q3 2024.
- A 3-year average of $611666.7 and a median of $705000.0 in 2023 define the central range for Gains from Sales and Divestitures.
- Peak YoY movement for Gains from Sales and Divestitures: crashed 71.91% in 2024, then soared 370.71% in 2025.
- Amdocs' Gains from Sales and Divestitures stood at $705000.0 in 2023, then plummeted by 71.91% to $198000.0 in 2024, then soared by 370.71% to $932000.0 in 2025.
- Per Business Quant, the three most recent readings for DOX's Gains from Sales and Divestitures are $932000.0 (Q3 2025), $198000.0 (Q3 2024), and $705000.0 (Q3 2023).